169 related articles for article (PubMed ID: 3085266)
1. The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase.
Kruithof EK; Tran-Thang C; Bachmann F
Thromb Haemost; 1986 Feb; 55(1):65-9. PubMed ID: 3085266
[TBL] [Abstract][Full Text] [Related]
2. Studies on the release of a plasminogen activator inhibitor by human platelets.
Kruithof EK; Tran-Thang C; Bachmann F
Thromb Haemost; 1986 Apr; 55(2):201-5. PubMed ID: 2940723
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
[TBL] [Abstract][Full Text] [Related]
4. On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasma.
Huisman LG; van Griensven JM; Kluft C
Thromb Haemost; 1995 Mar; 73(3):466-71. PubMed ID: 7667830
[TBL] [Abstract][Full Text] [Related]
5. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
Lijnen HR; Nelles L; Van Hoef B; De Cock F; Collen D
Thromb Haemost; 1988 Oct; 60(2):247-50. PubMed ID: 3146141
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
7. A novel fast inhibitor to tissue plasminogen activator in plasma, which may be of great pathophysiological significance.
Wiman B; Chmielewska J
Scand J Clin Lab Invest Suppl; 1985; 177():43-7. PubMed ID: 3934745
[TBL] [Abstract][Full Text] [Related]
8. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
[TBL] [Abstract][Full Text] [Related]
9. [Quantification of a specific inhibitor (PAI-1) of tissue-type plasminogen activator (t-PA) in the plasma].
Masson C; Angles-Cano E
Ann Biol Clin (Paris); 1989; 47(5):269-74. PubMed ID: 2500878
[TBL] [Abstract][Full Text] [Related]
10. Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.
Colucci M; Paramo JA; Stassen JM; Collen D
J Clin Invest; 1986 Jul; 78(1):138-44. PubMed ID: 3088040
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.
Verheijen JH; Chang GT; Kluft C
Thromb Haemost; 1984 Jul; 51(3):392-5. PubMed ID: 6437006
[TBL] [Abstract][Full Text] [Related]
12. Increased plasminogen activator inhibition levels in malignancy.
de Jong E; Knot EA; Piket D; Iburg AH; Rijken DC; Veenhof KH; Dooijewaard G; ten Cate JW
Thromb Haemost; 1987 Apr; 57(2):140-3. PubMed ID: 3110994
[TBL] [Abstract][Full Text] [Related]
13. Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators.
Kopitar M; Rozman B; Babnik J; Turk V; Mullins DE; Wun TC
Thromb Haemost; 1985 Dec; 54(4):750-5. PubMed ID: 3879018
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
[TBL] [Abstract][Full Text] [Related]
15. A sensitive assay, specific for endothelial cell type plasminogen activator inhibitor in blood plasma.
Sprengers ED
Thromb Haemost; 1986 Feb; 55(1):74-7. PubMed ID: 3085268
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies towards the fast inhibitor of tissue plasminogen activator from human plasma and serum.
Urdén G; Johansson U; Chmielewska J; Brandt J; Wiman B
Thromb Haemost; 1986 Jun; 55(3):383-7. PubMed ID: 3092395
[TBL] [Abstract][Full Text] [Related]
17. Release pattern of the vascular plasminogen activator and its inhibitor in human postvenous occlusion plasma as assessed by a spectrophotometric solid-phase fibrin-tPA activity assay.
Anglés-Cano E; Boutière B; Arnoux D; Masson C; Contant G; Benchimol P; Sampol J
Thromb Haemost; 1987 Oct; 58(3):843-9. PubMed ID: 3124285
[TBL] [Abstract][Full Text] [Related]
18. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
Kluft C; Jie AF; Rijken DC; Verheijen JH
Thromb Haemost; 1988 Apr; 59(2):329-32. PubMed ID: 3133814
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2.
Thorsen S; Philips M; Selmer J; Lecander I; Astedt B
Eur J Biochem; 1988 Jul; 175(1):33-9. PubMed ID: 3136015
[TBL] [Abstract][Full Text] [Related]
20. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]